NEVES, A. S.; http://lattes.cnpq.br/0479227925021149; NEVES, Adirliany Soares.
Résumé:
Chronic diseases are the leading cause of death and disability worldwide, especially cardiovascular diseases. Adequate food for health has aroused the interest of the scientific community, in order to show the influence of some foods in reducing the risk of these diseases. Flaxseed is influential in this group, has a high content of unsaturated lipids such as omega-3, fiber and lignans Numerous studies analyzed their protective potential, however, few describe physiological effects on the concentrations of plasma lipids, with an intake of 10 g and / or 20 capitas per g of crushed flaxseed. Due to the inconsistency of data, the present study aimed to evaluate the lipid and anthropometric profile of dyslipidemic women seen in Nova Floresta / PB before and after supplementation with different concentrations of brown flaxseed meal. A prospective longitudinal study of interventional clinical type, where the women were divided into three groups was developed: the control group received only dietotherapeutic intervention; LM 10g dietotherapeutic intervention group that received supplementation with 10g and flaxseed; 20g and the LM group that received intervention dietotherapeutic and 20g of flaxseed supplementation for 90 days. We used SPSS, version 20.0, IBM ® for descriptive and inferential analysis. The results showed a reduction of 1.98 kg / m2 on the differences between the mean BMI in the LM group 10 g (p <0.001) and in the LM group 20 g, observe a decline of 1.74 kg / m 2 (p <0.01) after the experiment. The DC cut 6.66 cm (p <0.001) and 4.66 cm (p <0.001) in the groups LM 10 20 LM g and g, respectively; however, none of these groups differed from the control group. The decreased HC at 3.50 cm 10g LM (p <0.001) and 4.0 cm in 20g LM (p <0.001). CB already showed a reduction of 1.33 cm (p <0.01) only in LM 10 g. As WHR, there were no changes in groups. For all variables, the groups LM LM 20 g 10 g and showed similar results. Regarding biochemical variables identified differences in reduction of mean blood glucose. Fasting 13.33 mg / dl (p <0.01) and 4.66 mg / dl (p <0.01) between LM and LM 10g 20g groups, respectively. Referring to triglycerides were decreased in 10g LM 34.33 mg / dl (p <0.01) and 55.33 mg / dl (p = 0.03) for the MT group 20g. However, there was no distinction between the experimental groups after the intervention. Taking into account a reduction in total cholesterol DLGG 10 g of 64.66 mg / dl (p <0.01) and 20 g of LM 20.33 mg / dl (p <0.01) was detected. HDL showed increased when there was supplemented with 2.33 g LM 10 mg / dl (p <0.01) and LDL decreased by 27.00 mg / dl (p <0.01). However, these lipoproteins did not change in LM 20 g. The reduction in VLDL had differences between means after intervention with LM 10g 7.33 mg / dL (p <0.01), which was not observed in LM 20 g group. However, it can be concluded that flaxseed consumption was effective in reducing anthropometric and biochemical measures, proving that the benefits derived from functional intake of flaxseed depend on the amount ingested.
